ERBB2 and breast carcinoma: We designed the present study to evaluate the concordance between IHC and quantitative reverse transcription polymerase chain reaction (qRT‐PCR) for the analysis of ER, PR, HER2, and Ki67 in breast cancer specimens that are defined as hormone receptor‐positive by IHC in local laboratories.